About Malens Pharmaceuticals Private Limited
Data last updated:
Malens Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 24 June 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2017PTC319753. Its GSTIN is 06AALCM1590K1Z5 (Haryana).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sorabh Tyagi and Sachin Kumar.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at 114/1 – F Rajpur Khurd Extension, New Delhi, Delhi, India – 110068.
As per the financials filed for FY 2023, the company reported a revenue of ₹40.43 Lakh, a growth of 43% compared to the previous year. For the same year it recorded a net loss of ₹28,976 (net margin -0.7%) and EBITDA of ₹1.3 Lakh (EBITDA margin 3.2%). Revenue has grown at a compounded annual rate (CAGR) of 41% over three years and 118% over five years.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website malenspharma.com.
Company details
Contact details
Malens Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its website is malenspharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address114/1 – F Rajpur Khurd Extension, New Delhi, Delhi, India – 110068
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Malens Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Malens Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Malens Pharmaceuticals Private Limited, buy the company report.
Financials of Malens Pharmaceuticals Private Limited
FY 2023 filings availableMalens Pharmaceuticals Private Limited reported revenue of ₹40.43 Lakh (up 43% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 118% over five years, including 43% growth in the latest year. EBITDA rose 45% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.3 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹28,976 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.2% | ||||
| Net Profit Margin | -0.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Malens Pharmaceuticals Private Limited, buy the company report.
Board of directors of Malens Pharmaceuticals Private Limited
Malens Pharmaceuticals has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sorabh Tyagi | Director | 26 Nov 2021 | 4 Years 10 Months | Current |
| Sachin Kumar | Director | 25 Sep 2021 | 5 Years 0 Months | Current |
Auditor
Malens Pharmaceuticals Private Limited is audited by AKANT HASIJA & ASSOCIATES for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AKANT HASIJA & ASSOCIATES | FY 2021 | 030214N |
Shareholding
The shareholding of Malens Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2021, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Malens Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Malens Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Malens Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Malens Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AALCM1590K1Z5 | Haryana | Active | 22 Jul 2017 |
To see the full GST registrations and return filing status of Malens Pharmaceuticals Private Limited, buy the company report.
Recent activity
Malens Pharmaceuticals Private Limited has 7 board changes on record since 2021: 2 appointments and 5 cessations. The latest: Sachin Kumar ceased to be Additional Director on 16 Jan 2022.
Frequently asked questions
Malens Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 24 June 2017 (9+ years old) and is registered under CIN U51909DL2017PTC319753.
Malens Pharmaceuticals has 2 current directors:
- Sorabh Tyagi - Director
- Sachin Kumar - Director
The latest financial statements of Malens Pharmaceuticals on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Malens Pharmaceuticals is 06AALCM1590K1Z5, registered in Haryana.
The CIN (Corporate Identification Number) of Malens Pharmaceuticals is U51909DL2017PTC319753. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Malens Pharmaceuticals was incorporated on 24 June 2017, making it 9+ years old. It is registered with the Registrar of Companies, Delhi.
Sachin Kumar ceased to be Additional Director on 16 Jan 2022. Ankit Pratap Singh ceased to be Additional Director on 26 Nov 2021. Sorabh Tyagi was appointed as Director on 26 Nov 2021. Malens Pharmaceuticals has 7 board changes on record in total.
Malens Pharmaceuticals can be reached through the website malenspharma.com. Its registered office is in New Delhi, Delhi, India.
The registered office of Malens Pharmaceuticals is at 1141 – F Rajpur Khurd Extension, New Delhi, Delhi, India – 110068.
Malens Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.